Prescription-drug pricing app GoodRX raises more than $1 billion in IPO, stock jumps more than 40% in debut

GoodRX priced shares well above range in initial public offering to raise at least $1.24 billion, including Silver Lake investment, at a valuation topping $12.6 billion
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.